Reviewnpj biomedical innovations2025

Exploring dopa decarboxylase as an ideal biomarker in Parkinson's disease with focus on regulatory mechanisms, cofactor influences, and metabolic implications.

Nourhan Shebl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.